Last updated on December 2017

A research study for patients who have been diagnosed with multiple sclerosis


Brief description of study

A research study for patients who have been diagnosed with multiple sclerosis

Detailed Study Description

The purpose of this study is to monitor the safety profile of an approved medication called fingolimod compared to other approved medications for the treatment of multiple sclerosis.

This is a mulitnational study which will include approximately 2400 patients. It is an observational study of patients who will be starting treatment with fingolimod or other approved multiple sclerosis medications or have started treatment within the past 6 months.

Clinical Study Identifier: TX138174

Find a site near you

Start Over

CHI St. Alexius Health

1310 East Main Ave., Suite 203 Bismarck, ND USA
  Connect »